1.The early diagnosis value of MRI for detecting spinal inflammatory lesions in ankylosing spondylitis
Ying LIU ; Chunhai LUO ; Shun QI ; Jianmin ZHENG ; Jing REN ; Junqing XU ; Guangquan WEI ; Jian XU ; Xing TANG ; Yuewen HAO ; Jinsong ZHANG
Journal of Practical Radiology 2015;(8):1322-1325
Objective To investigate the early diagnosis value of MR by detecting spinal inflammatory lesions in ankylosing spon-dylitis (AS).Methods Forty patients were involved in this study,including 20 cases with short inflammatory back pain (IBP)histo-ry (duration ≤18 months)and 20 cases with long IBP history (duration ≥24 months).MR images were analyzed retrospectively. Results Patients with a short history of IBP had 7 lesions in vertebral bodies (anterior/posterior spondylitis and spondylodiscitis) and 33 lesions in posterior spinal structures (arthritis of costovertebral joints,costotransversal joints,zygapophyseal joints and en-thesitis of spinal ligaments).Patients with a long history of IBP had 27 lesions in vertebral bodies and 24 lesions in posterior spinal structures.Patients with a short history of IBP had significantly more lesions in posterior spinal structures than in vertebral bodies with 82.5% (33/40)vs 1 7.5% (7/40),respectively (P <0.01).In contrast,patients with a long history of IBP had significantly more inflammation in vertebral bodies with 79.4% (27/34)vs 20.6% (7/34),respectively (P <0.01).Conclusion Inflammatory spinal lesions in patients with a short history of IBP are seen more often in the posterior structures.Early detection of inflammatory spinal lesions by MRI is useful for early diagnosis of AS.
2.Cocktail of chemical compounds robustly promoting cell reprogramming protects liver against acute injury.
Protein & Cell 2017;8(4):273-283
Tissue damage induces cells into reprogramming-like cellular state, which contributes to tissue regeneration. However, whether factors promoting the cell reprogramming favor tissue regeneration remains elusive. Here we identified combination of small chemical compounds including drug cocktails robustly promoting in vitro cell reprogramming. We then administrated the drug cocktails to mice with acute liver injuries induced by partial hepatectomy or toxic treatment. Our results demonstrated that the drug cocktails which promoted cell reprogramming in vitro improved liver regeneration and hepatic function in vivo after acute injuries. The underlying mechanism could be that expression of pluripotent genes activated after injury is further upregulated by drug cocktails. Thus our study offers proof-of-concept evidence that cocktail of clinical compounds improving cell reprogramming favors tissue recovery after acute damages, which is an attractive strategy for regenerative purpose.
Animals
;
Cellular Reprogramming
;
drug effects
;
Cellular Reprogramming Techniques
;
methods
;
Induced Pluripotent Stem Cells
;
cytology
;
metabolism
;
Mice
3.Targeted therapies for lupus nephritis: Current perspectives and future directions.
Xiuzhi JIA ; Yuewen LU ; Xunhua ZHENG ; Ruihan TANG ; Wei CHEN
Chinese Medical Journal 2024;137(1):34-43
Lupus nephritis (LN), a severe manifestation of systemic lupus erythematosus, poses a substantial risk of progression to end-stage renal disease, with increased mortality. Conventional therapy for LN relies on broad-spectrum immunosuppressants such as glucocorticoids, mycophenolate mofetil, and calcineurin inhibitors. Although therapeutic regimens have evolved over the years, they have inherent limitations, including non-specific targeting, substantial adverse effects, high relapse rates, and prolonged maintenance and remission courses. These drawbacks underscore the need for targeted therapeutic strategies for LN. Recent advancements in our understanding of LN pathogenesis have led to the identification of novel therapeutic targets and the emergence of biological agents and small-molecule inhibitors with improved specificity and reduced toxicity. This review provides an overview of the current evidence on targeted therapies for LN, elucidates the biological mechanisms of responses and failure, highlights the challenges ahead, and outlines strategies for subsequent clinical trials and integrated immunomodulatory approaches.
Humans
;
Calcineurin Inhibitors/therapeutic use*
;
Immunosuppressive Agents/therapeutic use*
;
Lupus Erythematosus, Systemic/drug therapy*
;
Lupus Nephritis/pathology*
;
Mycophenolic Acid/therapeutic use*
4. Design and clinical application of an information module for delirium assessment in ICU
Lijie QIAO ; Xiangping CHEN ; Yuewen LAO ; Lili SUN ; Qifeng TANG ; Yiyu ZHUANG
Chinese Journal of Practical Nursing 2019;35(30):2368-2373
Objective:
To investigate the effect of an information module for delirium assessment in ICU.
Methods:
The information module for delirium assessment was designed according to the route chart of the Confusion Assessment Method for the Intensive Care Unit(CAM-ICU) information assessment. Totally 70 nurses Sir Run Run Shaw Hospital, Zhejiang University School of Medicine were included in the application of the information module. The compliance and accuracy of the delirium assessment and acceptance of nurses' assessment of information module were compared.
Results:
The information module for delirium assessment was implanted into the clinical critical information system. The rate of compliance and accuracy of delirium assessed was 55.9%(2 728/4 877), 64.2%(231/360) before the application of information module, and 92.0%(4 360/4 740), 92.5%(333/360) after the application of information module. The difference between two groups were statistically significant (